Search is Powered by Google
Cancer / Oncology News

Gap In Black, White New Cancer Diagnoses Narrowing In Missouri; Mortality Rate Gap Falling More Slowly, Study Finds

Main Category: Cancer / Oncology
Also Included In: Public Health
Article Date: 26 Sep 2008 - 8:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The gap between blacks and whites in Missouri for newly diagnosed cancers is narrowing in part because of an overall decline in smoking and an increase in cancer screenings, according to a study to be published early next year in the journal Missouri Medicine, the AP/St. Louis Post-Dispatch reports. The study -- led by Mario Schootman, an associate professor of epidemiology and medicine at Washington University in St. Louis School of Medicine and head of the Siteman Cancer Center -- examined data from the Missouri Cancer Registry and the state Department of Health and Senior Services from 1990 to 2005.

According to the study, the rate of new cancer diagnoses for blacks was 18% higher than it was for whites in 1996, but by 2003 the gap fell to 6%. "If the trend continues, we expect the difference in new diagnos[es] for blacks and whites will disappear by 2006," Schootman said, noting that 2006 data are not yet available.

The study also found that although the black cancer mortality rate fell from 48% higher than that of whites in 1996 to 28% higher by 2005, it is expected to remain higher than that of whites for about 15 to 20 more years. The study also found that when compared with whites:


The study did not examine the reasons behind the findings, but Schootman said previous research has found that blacks have less access to care, do not get follow-up screenings or take advantage of available treatment, are not following healthy lifestyles and often have more aggressive tumors (Wittenauer, AP/St. Louis Post-Dispatch, 9/24).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...